HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David L McKinzie Selected Research

8- (4- methylpiperazin- 1- yl)- 3- phenylsulfonylquinoline

9/2010Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David L McKinzie Research Topics

Disease

10Schizophrenia (Dementia Praecox)
12/2015 - 11/2003
5Psychotic Disorders (Schizoaffective Disorder)
12/2013 - 04/2005
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 09/2010
4Mental Disorders (Mental Disorder)
07/2007 - 04/2005
2Chronic Pain
07/2018 - 12/2016
2Pain (Aches)
12/2016 - 03/2013
2Neurobehavioral Manifestations
10/2015 - 01/2012
2Cognitive Dysfunction
09/2010 - 03/2005
2Tremor (Tremors)
04/2003 - 04/2003
2Hypothermia
04/2003 - 04/2003
1Neuralgia (Stump Neuralgia)
12/2016
1Inflammation (Inflammations)
12/2016
1Mydriasis
10/2014
1Miosis
10/2014
1Pathologic Processes
03/2012
1Anxiety Disorders (Anxiety Disorder)
12/2005
1Cocaine-Related Disorders (Cocaine Addiction)
10/2003
1Bradycardia
04/2003
1Seizures (Absence Seizure)
04/2003

Drug/Important Bio-Agent (IBA)

6Glutamic Acid (Glutamate)FDA Link
12/2015 - 04/2005
5Cholinergic Agents (Cholinergics)IBA
10/2015 - 04/2003
5Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2013 - 04/2003
4Antipsychotic Agents (Antipsychotics)IBA
12/2015 - 04/2007
3Muscarinic AgonistsIBA
03/2005 - 04/2003
2EnzymesIBA
01/2022 - 01/2021
2Pharmaceutical PreparationsIBA
01/2021 - 02/2006
2Muscarinic M1 ReceptorIBA
10/2015 - 04/2003
2xanomelineIBA
01/2012 - 08/2008
24- aminho- 2- thiabicyclo(3.1.0)hexane- 4,6- dicarboxylic acidIBA
07/2007 - 04/2007
2HexanesIBA
04/2007 - 02/2006
2eglumetadIBA
04/2007 - 02/2006
2LY 379268IBA
04/2007 - 02/2006
1Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
01/2022
1Amyloid beta-PeptidesIBA
01/2021
1Freund's AdjuvantIBA
12/2016
1Sucrose (Saccharose)IBA
12/2016
1pomaglumetad methionilIBA
12/2015
1Risperidone (Risperdal Consta)FDA LinkGeneric
12/2015
1mu Opioid Receptors (mu Opioid Receptor)IBA
10/2014
1Naltrexone (ReVia)FDA LinkGeneric
10/2014
1Narcotic Antagonists (Opioid Antagonists)IBA
10/2014
1AticaprantIBA
10/2014
1Morphine (MS Contin)FDA LinkGeneric
10/2014
1Naloxone (Narcan)FDA LinkGeneric
10/2014
1Fentanyl (Sublimaze)FDA LinkGeneric
10/2014
1Analgesics (Analgesic Drugs)IBA
03/2013
1N-dodecyl-L-lysine amideIBA
03/2013
1Formaldehyde (Formol)FDA Link
03/2013
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
03/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2012
1LY 2140023IBA
03/2012
1Phencyclidine (Angel Dust)IBA
09/2010
18- (4- methylpiperazin- 1- yl)- 3- phenylsulfonylquinolineIBA
09/2010
1(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA
09/2010
1Acetylcholine (Acetylcholine Chloride)FDA Link
08/2008
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2007
1AcidsIBA
02/2006
12- ((2'- amino)propionyl)aminobicyclo(3.1.0)hexane- 2,6- dicarboxylic acidIBA
02/2006
1ProdrugsIBA
02/2006
1diphenyl (biphenyl)IBA
04/2005
1SulfonamidesIBA
04/2005
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
11/2003
1Lysergic Acid Diethylamide (LSD)IBA
11/2003
1Dopamine Agents (Dopaminergic Agents)IBA
11/2003
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
11/2003
1ParasympathomimeticsIBA
04/2003
1OxotremorineIBA
04/2003
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2003
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2003

Therapy/Procedure

2Ligation
07/2018 - 12/2016
2Drug Therapy (Chemotherapy)
12/2015 - 09/2010
1Induced Hyperthermia (Thermotherapy)
12/2005